Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis (RA) and Crohn's Disease (CD)
Clinical trial NCT01577264 · TERMINATED
Trial details
- NCT number
- NCT01577264
- Sponsor
- UCB Pharma
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2011-08-01
- Primary completion
- 2015-10-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.